aluates Reports

$ 0.0

Automative

Global Gene Delivery System Market Research Report 2026

Published Date: 2026-04-10

Report Code: QYRE-Auto-27Z8927

Global Gene Delivery System Market Size Status and Forecast 2022

BUY CHAPTERS

Global Gene Delivery System Market Research Report 2026

Code: QYRE-Auto-27Z8927

Report

2026-04-10

Pages:131

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Gilead Sciences

Sarepta Therapeutics

Alnylam Pharmaceuticals

Amgen Inc

Spark Therapeutics

Akcea Therapeutics

Sunway Biotech

Sibiono

AnGes

Orchard Therapeutics

Human Stem Cells Institute

Novartis

Biogen

Adaptimmune

Krystal Biotech

Vertex Pharmaceuticals

CSL Behring

Gene Delivery System Market Size

The global Gene Delivery System market was valued at US$ 14330 million in 2025 and is anticipated to reach US$ 77240 million by 2032, at a CAGR of 27.6% from 2026 to 2032.

Gene Delivery System Market

Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.

The gene delivery system market is experiencing rapid growth, primarily driven by advancements in gene therapy, personalized medicine, and biotechnology research. The increasing prevalence of genetic disorders, cancers, and rare diseases has fueled demand for targeted and effective gene-based treatments. Innovations in delivery vectors—such as viral systems (adenoviral, lentiviral) and non-viral methods (lipid nanoparticles, polymers, and electroporation)—are enabling more precise and efficient gene delivery. Additionally, the success of mRNA-based COVID-19 vaccines has accelerated investment and trust in nucleic acid delivery platforms. Supportive regulatory policies, increased R&D funding from both government and private sectors, and rising collaborations between pharmaceutical companies and academic institutions are further boosting the global gene delivery market.

Despite significant advancements, the gene delivery system market faces several complex challenges. One major hurdle is ensuring safe, efficient, and tissue-specific delivery of genetic material without triggering immune responses or toxicity. Viral vectors, while effective, can carry risks such as insertional mutagenesis or immunogenicity, limiting their long-term application. Non-viral vectors, on the other hand, often face limitations in transfection efficiency and stability. Manufacturing scalability and quality control also remain problematic, especially for complex delivery systems. Moreover, the high cost of gene therapies and the limited availability of clinical-grade vectors pose barriers to broader adoption, particularly in low- and middle-income countries. Navigating diverse regulatory frameworks globally adds another layer of complexity for companies operating across borders.

This report delivers a comprehensive overview of the global Gene Delivery System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Gene Delivery System. The Gene Delivery System market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Gene Delivery System market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Gene Delivery System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Gene Delivery System Market Report

Report Metric	Details
Report Name	Gene Delivery System Market
Accounted market size in 2025	US$ 14330 million
Forecasted market size in 2032	US$ 77240 million
CAGR	27.6%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Viral Gene Delivery System Non-viral Gene Delivery System
Segment by Application	Neurological Diseases Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute, Adaptimmune, Krystal Biotech, Vertex Pharmaceuticals, CSL Behring
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Gene Delivery System companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Gene Delivery System Market growing?

Ans: The Gene Delivery System Market witnessing a CAGR of 27.6% during the forecast period 2026-2032.

What is the Gene Delivery System Market size in 2032?

Ans: The Gene Delivery System Market size in 2032 will be US$ 77240 million.

Who are the main players in the Gene Delivery System Market report?

Ans: The main players in the Gene Delivery System Market are Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute, Adaptimmune, Krystal Biotech, Vertex Pharmaceuticals, CSL Behring

What are the Application segmentation covered in the Gene Delivery System Market report?

Ans: The Applications covered in the Gene Delivery System Market report are Neurological Diseases, Cancer, Others

What are the Type segmentation covered in the Gene Delivery System Market report?

Ans: The Types covered in the Gene Delivery System Market report are Viral Gene Delivery System, Non-viral Gene Delivery System

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gene Delivery System Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Viral Gene Delivery System

1.2.3 Non-viral Gene Delivery System

1.3 Market by Application

1.3.1 Global Gene Delivery System Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Neurological Diseases

1.3.3 Cancer

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gene Delivery System Market Perspective (2021–2032)

2.2 Global Gene Delivery System Growth Trends by Region

2.2.1 Global Gene Delivery System Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Gene Delivery System Historic Market Size by Region (2021–2026)

2.2.3 Gene Delivery System Forecasted Market Size by Region (2027–2032)

2.3 Gene Delivery System Market Dynamics

2.3.1 Gene Delivery System Industry Trends

2.3.2 Gene Delivery System Market Drivers

2.3.3 Gene Delivery System Market Challenges

2.3.4 Gene Delivery System Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gene Delivery System Players by Revenue

3.1.1 Global Top Gene Delivery System Players by Revenue (2021–2026)

3.1.2 Global Gene Delivery System Revenue Market Share by Players (2021–2026)

3.2 Global Top Gene Delivery System Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Gene Delivery System Revenue

3.4 Global Gene Delivery System Market Concentration Ratio

3.4.1 Global Gene Delivery System Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gene Delivery System Revenue in 2025

3.5 Global Key Players of Gene Delivery System Head Offices and Areas Served

3.6 Global Key Players of Gene Delivery System, Products and Applications

3.7 Global Key Players of Gene Delivery System, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Gene Delivery System Breakdown Data by Type

4.1 Global Gene Delivery System Historic Market Size by Type (2021–2026)

4.2 Global Gene Delivery System Forecasted Market Size by Type (2027–2032)

5 Gene Delivery System Breakdown Data by Application

5.1 Global Gene Delivery System Historic Market Size by Application (2021–2026)

5.2 Global Gene Delivery System Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Gene Delivery System Market Size (2021–2032)

6.2 North America Gene Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Gene Delivery System Market Size by Country (2021–2026)

6.4 North America Gene Delivery System Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gene Delivery System Market Size (2021–2032)

7.2 Europe Gene Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Gene Delivery System Market Size by Country (2021–2026)

7.4 Europe Gene Delivery System Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Gene Delivery System Market Size (2021–2032)

8.2 Asia-Pacific Gene Delivery System Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Gene Delivery System Market Size by Region (2021–2026)

8.4 Asia-Pacific Gene Delivery System Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Gene Delivery System Market Size (2021–2032)

9.2 Latin America Gene Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Gene Delivery System Market Size by Country (2021–2026)

9.4 Latin America Gene Delivery System Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gene Delivery System Market Size (2021–2032)

10.2 Middle East & Africa Gene Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Gene Delivery System Market Size by Country (2021–2026)

10.4 Middle East & Africa Gene Delivery System Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Biogen

11.1.1 Biogen Company Details

11.1.2 Biogen Business Overview

11.1.3 Biogen Gene Delivery System Introduction

11.1.4 Biogen Revenue in Gene Delivery System Business (2021–2026)

11.1.5 Biogen Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Gene Delivery System Introduction

11.2.4 Novartis Revenue in Gene Delivery System Business (2021–2026)

11.2.5 Novartis Recent Development

11.3 Gilead Sciences

11.3.1 Gilead Sciences Company Details

11.3.2 Gilead Sciences Business Overview

11.3.3 Gilead Sciences Gene Delivery System Introduction

11.3.4 Gilead Sciences Revenue in Gene Delivery System Business (2021–2026)

11.3.5 Gilead Sciences Recent Development

11.4 Sarepta Therapeutics

11.4.1 Sarepta Therapeutics Company Details

11.4.2 Sarepta Therapeutics Business Overview

11.4.3 Sarepta Therapeutics Gene Delivery System Introduction

11.4.4 Sarepta Therapeutics Revenue in Gene Delivery System Business (2021–2026)

11.4.5 Sarepta Therapeutics Recent Development

11.5 Alnylam Pharmaceuticals

11.5.1 Alnylam Pharmaceuticals Company Details

11.5.2 Alnylam Pharmaceuticals Business Overview

11.5.3 Alnylam Pharmaceuticals Gene Delivery System Introduction

11.5.4 Alnylam Pharmaceuticals Revenue in Gene Delivery System Business (2021–2026)

11.5.5 Alnylam Pharmaceuticals Recent Development

11.6 Amgen

11.6.1 Amgen Company Details

11.6.2 Amgen Business Overview

11.6.3 Amgen Gene Delivery System Introduction

11.6.4 Amgen Revenue in Gene Delivery System Business (2021–2026)

11.6.5 Amgen Recent Development

11.7 Spark Therapeutics

11.7.1 Spark Therapeutics Company Details

11.7.2 Spark Therapeutics Business Overview

11.7.3 Spark Therapeutics Gene Delivery System Introduction

11.7.4 Spark Therapeutics Revenue in Gene Delivery System Business (2021–2026)

11.7.5 Spark Therapeutics Recent Development

11.8 Akcea Therapeutics

11.8.1 Akcea Therapeutics Company Details

11.8.2 Akcea Therapeutics Business Overview

11.8.3 Akcea Therapeutics Gene Delivery System Introduction

11.8.4 Akcea Therapeutics Revenue in Gene Delivery System Business (2021–2026)

11.8.5 Akcea Therapeutics Recent Development

11.9 Sunway Biotech

11.9.1 Sunway Biotech Company Details

11.9.2 Sunway Biotech Business Overview

11.9.3 Sunway Biotech Gene Delivery System Introduction

11.9.4 Sunway Biotech Revenue in Gene Delivery System Business (2021–2026)

11.9.5 Sunway Biotech Recent Development

11.10 SIBIONO

11.10.1 SIBIONO Company Details

11.10.2 SIBIONO Business Overview

11.10.3 SIBIONO Gene Delivery System Introduction

11.10.4 SIBIONO Revenue in Gene Delivery System Business (2021–2026)

11.10.5 SIBIONO Recent Development

11.11 AnGes

11.11.1 AnGes Company Details

11.11.2 AnGes Business Overview

11.11.3 AnGes Gene Delivery System Introduction

11.11.4 AnGes Revenue in Gene Delivery System Business (2021–2026)

11.11.5 AnGes Recent Development

11.12 Orchard Therapeutics

11.12.1 Orchard Therapeutics Company Details

11.12.2 Orchard Therapeutics Business Overview

11.12.3 Orchard Therapeutics Gene Delivery System Introduction

11.12.4 Orchard Therapeutics Revenue in Gene Delivery System Business (2021–2026)

11.12.5 Orchard Therapeutics Recent Development

11.13 Human Stem Cells Institute

11.13.1 Human Stem Cells Institute Company Details

11.13.2 Human Stem Cells Institute Business Overview

11.13.3 Human Stem Cells Institute Gene Delivery System Introduction

11.13.4 Human Stem Cells Institute Revenue in Gene Delivery System Business (2021–2026)

11.13.5 Human Stem Cells Institute Recent Development

11.14 Adaptimmune

11.14.1 Adaptimmune Company Details

11.14.2 Adaptimmune Business Overview

11.14.3 Adaptimmune Gene Delivery System Introduction

11.14.4 Adaptimmune Revenue in Gene Delivery System Business (2021–2026)

11.14.5 Adaptimmune Recent Development

11.15 Krystal Biotech

11.15.1 Krystal Biotech Company Details

11.15.2 Krystal Biotech Business Overview

11.15.3 Krystal Biotech Gene Delivery System Introduction

11.15.4 Krystal Biotech Revenue in Gene Delivery System Business (2021–2026)

11.15.5 Krystal Biotech Recent Development

11.16 Vertex Pharmaceuticals

11.16.1 Vertex Pharmaceuticals Company Details

11.16.2 Vertex Pharmaceuticals Business Overview

11.16.3 Vertex Pharmaceuticals Gene Delivery System Introduction

11.16.4 Vertex Pharmaceuticals Revenue in Gene Delivery System Business (2021–2026)

11.16.5 Vertex Pharmaceuticals Recent Development

11.17 CSL Behring

11.17.1 CSL Behring Company Details

11.17.2 CSL Behring Business Overview

11.17.3 CSL Behring Gene Delivery System Introduction

11.17.4 CSL Behring Revenue in Gene Delivery System Business (2021–2026)

11.17.5 CSL Behring Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Gilead Sciences

Sarepta Therapeutics

Alnylam Pharmaceuticals

Amgen Inc

Spark Therapeutics

Akcea Therapeutics

Sunway Biotech

Sibiono

AnGes

Orchard Therapeutics

Human Stem Cells Institute

Novartis

Biogen

Adaptimmune

Krystal Biotech

Vertex Pharmaceuticals

CSL Behring

List of Tables

Table 1. Global Gene Delivery System Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Viral Gene Delivery System

Table 3. Key Players of Non-viral Gene Delivery System

Table 4. Global Gene Delivery System Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Gene Delivery System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Gene Delivery System Market Size by Region (US$ Million), 2021–2026

Table 7. Global Gene Delivery System Market Share by Region (2021–2026)

Table 8. Global Gene Delivery System Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Gene Delivery System Market Share by Region (2027–2032)

Table 10. Gene Delivery System Market Trends

Table 11. Gene Delivery System Market Drivers

Table 12. Gene Delivery System Market Challenges

Table 13. Gene Delivery System Market Restraints

Table 14. Global Gene Delivery System Revenue by Players (US$ Million), 2021–2026

Table 15. Global Gene Delivery System Market Share by Players (2021–2026)

Table 16. Global Top Gene Delivery System Players by Tier (Tier 1, Tier 2, and Tier 3), based on Gene Delivery System Revenue, 2025

Table 17. Ranking of Global Top Gene Delivery System Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Gene Delivery System Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Gene Delivery System, Headquarters and Area Served

Table 20. Global Key Players of Gene Delivery System, Products and Applications

Table 21. Global Key Players of Gene Delivery System, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Gene Delivery System Market Size by Type (US$ Million), 2021–2026

Table 24. Global Gene Delivery System Revenue Market Share by Type (2021–2026)

Table 25. Global Gene Delivery System Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Gene Delivery System Revenue Market Share by Type (2027–2032)

Table 27. Global Gene Delivery System Market Size by Application (US$ Million), 2021–2026

Table 28. Global Gene Delivery System Revenue Market Share by Application (2021–2026)

Table 29. Global Gene Delivery System Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Gene Delivery System Revenue Market Share by Application (2027–2032)

Table 31. North America Gene Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Gene Delivery System Market Size by Country (US$ Million), 2021–2026

Table 33. North America Gene Delivery System Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Gene Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Gene Delivery System Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Gene Delivery System Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Gene Delivery System Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Gene Delivery System Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Gene Delivery System Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Gene Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Gene Delivery System Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Gene Delivery System Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Gene Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Gene Delivery System Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Gene Delivery System Market Size by Country (US$ Million), 2027–2032

Table 46. Biogen Company Details

Table 47. Biogen Business Overview

Table 48. Biogen Gene Delivery System Product

Table 49. Biogen Revenue in Gene Delivery System Business (US$ Million), 2021–2026

Table 50. Biogen Recent Development

Table 51. Novartis Company Details

Table 52. Novartis Business Overview

Table 53. Novartis Gene Delivery System Product

Table 54. Novartis Revenue in Gene Delivery System Business (US$ Million), 2021–2026

Table 55. Novartis Recent Development

Table 56. Gilead Sciences Company Details

Table 57. Gilead Sciences Business Overview

Table 58. Gilead Sciences Gene Delivery System Product

Table 59. Gilead Sciences Revenue in Gene Delivery System Business (US$ Million), 2021–2026

Table 60. Gilead Sciences Recent Development

Table 61. Sarepta Therapeutics Company Details

Table 62. Sarepta Therapeutics Business Overview

Table 63. Sarepta Therapeutics Gene Delivery System Product

Table 64. Sarepta Therapeutics Revenue in Gene Delivery System Business (US$ Million), 2021–2026

Table 65. Sarepta Therapeutics Recent Development

Table 66. Alnylam Pharmaceuticals Company Details

Table 67. Alnylam Pharmaceuticals Business Overview

Table 68. Alnylam Pharmaceuticals Gene Delivery System Product

Table 69. Alnylam Pharmaceuticals Revenue in Gene Delivery System Business (US$ Million), 2021–2026

Table 70. Alnylam Pharmaceuticals Recent Development

Table 71. Amgen Company Details

Table 72. Amgen Business Overview

Table 73. Amgen Gene Delivery System Product

Table 74. Amgen Revenue in Gene Delivery System Business (US$ Million), 2021–2026

Table 75. Amgen Recent Development

Table 76. Spark Therapeutics Company Details

Table 77. Spark Therapeutics Business Overview

Table 78. Spark Therapeutics Gene Delivery System Product

Table 79. Spark Therapeutics Revenue in Gene Delivery System Business (US$ Million), 2021–2026

Table 80. Spark Therapeutics Recent Development

Table 81. Akcea Therapeutics Company Details

Table 82. Akcea Therapeutics Business Overview

Table 83. Akcea Therapeutics Gene Delivery System Product

Table 84. Akcea Therapeutics Revenue in Gene Delivery System Business (US$ Million), 2021–2026

Table 85. Akcea Therapeutics Recent Development

Table 86. Sunway Biotech Company Details

Table 87. Sunway Biotech Business Overview

Table 88. Sunway Biotech Gene Delivery System Product

Table 89. Sunway Biotech Revenue in Gene Delivery System Business (US$ Million), 2021–2026

Table 90. Sunway Biotech Recent Development

Table 91. SIBIONO Company Details

Table 92. SIBIONO Business Overview

Table 93. SIBIONO Gene Delivery System Product

Table 94. SIBIONO Revenue in Gene Delivery System Business (US$ Million), 2021–2026

Table 95. SIBIONO Recent Development

Table 96. AnGes Company Details

Table 97. AnGes Business Overview

Table 98. AnGes Gene Delivery System Product

Table 99. AnGes Revenue in Gene Delivery System Business (US$ Million), 2021–2026

Table 100. AnGes Recent Development

Table 101. Orchard Therapeutics Company Details

Table 102. Orchard Therapeutics Business Overview

Table 103. Orchard Therapeutics Gene Delivery System Product

Table 104. Orchard Therapeutics Revenue in Gene Delivery System Business (US$ Million), 2021–2026

Table 105. Orchard Therapeutics Recent Development

Table 106. Human Stem Cells Institute Company Details

Table 107. Human Stem Cells Institute Business Overview

Table 108. Human Stem Cells Institute Gene Delivery System Product

Table 109. Human Stem Cells Institute Revenue in Gene Delivery System Business (US$ Million), 2021–2026

Table 110. Human Stem Cells Institute Recent Development

Table 111. Adaptimmune Company Details

Table 112. Adaptimmune Business Overview

Table 113. Adaptimmune Gene Delivery System Product

Table 114. Adaptimmune Revenue in Gene Delivery System Business (US$ Million), 2021–2026

Table 115. Adaptimmune Recent Development

Table 116. Krystal Biotech Company Details

Table 117. Krystal Biotech Business Overview

Table 118. Krystal Biotech Gene Delivery System Product

Table 119. Krystal Biotech Revenue in Gene Delivery System Business (US$ Million), 2021–2026

Table 120. Krystal Biotech Recent Development

Table 121. Vertex Pharmaceuticals Company Details

Table 122. Vertex Pharmaceuticals Business Overview

Table 123. Vertex Pharmaceuticals Gene Delivery System Product

Table 124. Vertex Pharmaceuticals Revenue in Gene Delivery System Business (US$ Million), 2021–2026

Table 125. Vertex Pharmaceuticals Recent Development

Table 126. CSL Behring Company Details

Table 127. CSL Behring Business Overview

Table 128. CSL Behring Gene Delivery System Product

Table 129. CSL Behring Revenue in Gene Delivery System Business (US$ Million), 2021–2026

Table 130. CSL Behring Recent Development

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

Table 134. Authors List of This Report

List of Figures

Figure 1. Gene Delivery System Picture

Figure 2. Global Gene Delivery System Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Gene Delivery System Market Share by Type: 2025 vs 2032

Figure 4. Viral Gene Delivery System Features

Figure 5. Non-viral Gene Delivery System Features

Figure 6. Global Gene Delivery System Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Gene Delivery System Market Share by Application: 2025 vs 2032

Figure 8. Neurological Diseases Case Studies

Figure 9. Cancer Case Studies

Figure 10. Others Case Studies

Figure 11. Gene Delivery System Report Years Considered

Figure 12. Global Gene Delivery System Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 13. Global Gene Delivery System Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Gene Delivery System Market Share by Region: 2025 vs 2032

Figure 15. Global Gene Delivery System Market Share by Players in 2025

Figure 16. Global Gene Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Gene Delivery System Revenue in 2025

Figure 18. North America Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 19. North America Gene Delivery System Market Share by Country (2021–2032)

Figure 20. United States Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Canada Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Gene Delivery System Market Share by Country (2021–2032)

Figure 24. Germany Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. France Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. U.K. Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Italy Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Russia Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Ireland Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Gene Delivery System Market Share by Region (2021–2032)

Figure 32. China Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Japan Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. South Korea Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Southeast Asia Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. India Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Australia & New Zealand Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Gene Delivery System Market Share by Country (2021–2032)

Figure 40. Mexico Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Brazil Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Gene Delivery System Market Share by Country (2021–2032)

Figure 44. Israel Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Saudi Arabia Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. UAE Gene Delivery System Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Biogen Revenue Growth Rate in Gene Delivery System Business (2021–2026)

Figure 48. Novartis Revenue Growth Rate in Gene Delivery System Business (2021–2026)

Figure 49. Gilead Sciences Revenue Growth Rate in Gene Delivery System Business (2021–2026)

Figure 50. Sarepta Therapeutics Revenue Growth Rate in Gene Delivery System Business (2021–2026)

Figure 51. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Delivery System Business (2021–2026)

Figure 52. Amgen Revenue Growth Rate in Gene Delivery System Business (2021–2026)

Figure 53. Spark Therapeutics Revenue Growth Rate in Gene Delivery System Business (2021–2026)

Figure 54. Akcea Therapeutics Revenue Growth Rate in Gene Delivery System Business (2021–2026)

Figure 55. Sunway Biotech Revenue Growth Rate in Gene Delivery System Business (2021–2026)

Figure 56. SIBIONO Revenue Growth Rate in Gene Delivery System Business (2021–2026)

Figure 57. AnGes Revenue Growth Rate in Gene Delivery System Business (2021–2026)

Figure 58. Orchard Therapeutics Revenue Growth Rate in Gene Delivery System Business (2021–2026)

Figure 59. Human Stem Cells Institute Revenue Growth Rate in Gene Delivery System Business (2021–2026)

Figure 60. Adaptimmune Revenue Growth Rate in Gene Delivery System Business (2021–2026)

Figure 61. Krystal Biotech Revenue Growth Rate in Gene Delivery System Business (2021–2026)

Figure 62. Vertex Pharmaceuticals Revenue Growth Rate in Gene Delivery System Business (2021–2026)

Figure 63. CSL Behring Revenue Growth Rate in Gene Delivery System Business (2021–2026)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Gene based Therapy Medicinal Market Research Report 2024

Global Gene based Advanced Therapy Medicinal Market Research Report 2025

Gene Delivery System Technology Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drugs Based on Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Delivery System for Gene Therapy Market Research Report 2025

Gene Therapy on Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gene Therapy based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug Based on Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gene based Advanced Therapy Medical Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Gene Therapy Market Research Report 2025

Global Gene Therapy Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Gene Therapy on Neurological Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Viral Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gene Therapy in Cardiovascular Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Therapy For Cancer Market Research Report 2024

Global Gene Therapies for Cancer Treatment Market Research Report 2024

Global Gene Therapy On Cardiovascular Disease Market Research Report 2025

Global Gene Delivery Technologies Market Research Report 2024

Global Cell and Gene Therapy Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions